Literature DB >> 18617575

Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element.

Gilles A Robichaud1, Jean-Pierre Perreault, Rodney J Ouellette.   

Abstract

The transcription factor Pax-5, is vital during B lymphocyte differentiation and is known to contribute to the oncogenesis of certain cancers. The Pax-5 locus generates multiple yet structurally related mRNA transcripts through the specific activation of alternative promoter regions and/or alternative splicing events which poses challenges in the study of specific isoform function. In this study, we investigated the function of a major Pax-5 transcript, Pax-5B using an enhanced version of the Hepatitis Delta Virus ribozyme (HDV Rz) suppression system that is specifically designed to recognize and cleave the human Pax-5B mRNA. The activity of these ribozymes resulted in the specific suppression of the Pax-5B transcripts without altering the transcript levels of other closely related Pax-5 isoforms mRNAs both in vitro and in an intracellular setting. Following stable transfection of the ribozymes into a model B cell line (REH), we showed that Pax-5B suppression led to an increase of CD19 mRNA and cell surface protein expression. In response to this Pax-5B specific deregulation, a marked increase in apoptotic activity compared to control cell lines was observed. These results suggest that Pax-5B has distinct roles in physiological processes in cell fate events during lymphocyte development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617575      PMCID: PMC2504290          DOI: 10.1093/nar/gkn432

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

Review 1.  Getting your Pax straight: Pax proteins in development and disease.

Authors:  Neil Chi; Jonathan A Epstein
Journal:  Trends Genet       Date:  2002-01       Impact factor: 11.639

2.  Functional characterization of the SOFA delta ribozyme.

Authors:  Lucien Junior Bergeron; Cédric Reymond; Jean-Pierre Perreault
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

3.  Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.

Authors:  M Busslinger; N Klix; P Pfeffer; P G Graninger; Z Kozmik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 4.  The BCR signalosome: where cell fate is decided.

Authors:  C Ulivieri; C T Baldari
Journal:  J Biol Regul Homeost Agents       Date:  2005 Jan-Jun       Impact factor: 1.711

5.  Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells.

Authors:  Gilles A Robichaud; Michel Nardini; Mark Laflamme; Miroslava Cuperlovic-Culf; Rodney J Ouellette
Journal:  J Biol Chem       Date:  2004-09-22       Impact factor: 5.157

6.  Identification of Pax5 target genes in early B cell differentiation.

Authors:  Clare Pridans; Melissa L Holmes; Matthew Polli; James M Wettenhall; Aleksandar Dakic; Lynn M Corcoran; Gordon K Smyth; Stephen L Nutt
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.

Authors:  P Zwollo; S Desiderio
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

8.  The role of BSAP in immunoglobulin isotype switching and B-cell proliferation.

Authors:  E E Max; Y Wakatsuki; M F Neurath; W Strober
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

9.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.

Authors:  B Adams; P Dörfler; A Aguzzi; Z Kozmik; P Urbánek; I Maurer-Fogy; M Busslinger
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

View more
  11 in total

1.  Investigating a new generation of ribozymes in order to target HCV.

Authors:  Michel V Lévesque; Dominique Lévesque; Francis P Brière; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

2.  Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting.

Authors:  Michel V Lévesque; Samuel G Rouleau; Jean-Pierre Perreault
Journal:  Nucleic Acid Ther       Date:  2011-07-08       Impact factor: 5.486

3.  Silencing of amyloid precursor protein expression using a new engineered delta ribozyme.

Authors:  Manel Ben Aissa; Marie-Claude April; Lucien-Junior Bergeron; Jean-Pierre Perreault; Georges Levesque
Journal:  Int J Alzheimers Dis       Date:  2012-02-12

4.  A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.

Authors:  Julie Motard; Ronan Rouxel; Alexandra Paun; Veronika von Messling; Martin Bisaillon; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

5.  Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.

Authors:  S Kasar; C Underbayev; Y Yuan; M Hanlon; S Aly; H Khan; V Chang; M Batish; T Gavrilova; F Badiane; H Degheidy; G Marti; E Raveche
Journal:  Oncogene       Date:  2013-09-02       Impact factor: 9.867

6.  Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways.

Authors:  Sami Benzina; Jason Harquail; Roxann Guerrette; Pierre O'Brien; Stéphanie Jean; Nicolas Crapoulet; Gilles A Robichaud
Journal:  J Cancer       Date:  2016-10-22       Impact factor: 4.207

7.  PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation.

Authors:  Charlotte Cresson; Sophie Péron; Laura Jamrog; Nelly Rouquié; Nais Prade; Marine Dubois; Sylvie Hébrard; Stéphanie Lagarde; Bastien Gerby; Stéphane J C Mancini; Michel Cogné; Eric Delabesse; Laurent Delpy; Cyril Broccardo
Journal:  Oncotarget       Date:  2018-08-28

8.  Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing.

Authors:  Annie-Pier Beauregard; Brandon Hannay; Ehsan Gharib; Nicolas Crapoulet; Nicholas Finn; Roxann Guerrette; Amélie Ouellet; Gilles A Robichaud
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

Review 9.  Modulating RNA structure and catalysis: lessons from small cleaving ribozymes.

Authors:  Cedric Reymond; Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  Cell Mol Life Sci       Date:  2009-08-30       Impact factor: 9.261

10.  A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.

Authors:  Robert J Scarborough; Michel V Lévesque; Etienne Boudrias-Dalle; Ian C Chute; Sylvanne M Daniels; Rodney J Ouellette; Jean-Pierre Perreault; Anne Gatignol
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-29       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.